CN102716471A

CN102716471A - Anti-hyperlipidemia health-care product

Info

Publication number: CN102716471A
Application number: CN201210226426XA
Authority: CN
Inventors: 童长虹
Original assignee: Individual
Current assignee: Individual
Priority date: 2012-07-03
Filing date: 2012-07-03
Publication date: 2012-10-10

Abstract

The invention relates to an anti-hyperlipidemia health-care product. The technical scheme disclosed by the invention is that the anti-hyperlipidemia health-care product is prepared from the following crude drugs in parts by weight: 150 parts of nattokinase, 40-60 parts of hirudin, 20-40 parts of lumbricus, 40-60 parts of medlar and 10-30 parts of hawthorn. The crude drugs are evenly mixed in parts by weight to prepare tablets, capsules or pills. According to the anti-hyperlipidemia health-care product, through adopting the technology of homology of medicine and food, blood fat can be lowered, and the blood viscosity reaches within a normal range through the synergistic effect between traditional Chinese medicines and food. As the traditional Chinese medicines are combined with the food, the toxic and side effects are small, whereas the anti-hyperlipidemia curative effect is high.

Description

A kind of health product of blood fat reducing

Technical field

The invention belongs to field of health care products, relate to a kind of health product particularly with lipid-lowering effect.

Background technology

Lipoid material in the blood is referred to as blood fat.Lipid in the blood plasma comprises cholesterol, triglyceride, phospholipid and non-free fatty etc.Blood fat is a kind of important material in the human body, and many very important functions are arranged, but can not surpass certain scope.Hyperlipidemia is meant blood cholesterol (TC) and/or triglyceride (TG) is too high or HDL-C (HDL-C) is low excessively.At present, the patient of hyperlipidemia is very general.The harm of hyperlipidemia is: if hyperlipoidemia causes " blood is thick " easily, on blood vessel wall, deposit, form little speckle gradually, these " specklees " increase, increase, and artery-clogging makes blood flow slack-off gradually, and blood flow is interrupted when serious.If this situation occurs in heart, just cause coronary heart disease; Occur in brain, apoplexy will occur; If the obstruction optical fundus blood vessel will cause visual deterioration, blind; If occur in kidney, will cause renal arteriosclerosis, renal failure; Occur in lower limb, limb necrosis can occur, fester etc.In addition, hyperlipidemia can cause hypertension, brings out cholelithiasis, pancreatitis, increases the weight of hepatitis, causes male sexual disorder, disease such as senile dementia.Current research prompting hyperlipidemia maybe be relevant with the morbidity of cancer.

The method of existing blood fat reducing is mainly western medicine therapy, and chemical synthetic drug has certain toxic and side effects, therefore needs the exploitation toxic and side effects little, the health product of the blood fat reducing of integration of edible and medicinal herbs.

Summary of the invention

In order to overcome the above problems, the present invention provides a kind of integration of edible and medicinal herbs, has the health product of lipid-lowering effect.

The technical scheme that the present invention adopts is: a kind of health product of blood fat reducing, process by following raw material medicaments in part by weight proportioning:

150 parts of nattokinase, hirudin 40-60 part, Pheretima 20-40 part, Fructus Lycii 40-60 part,

Fructus Crataegi 10-30 part, Radix Salviae Miltiorrhizae 40-60 part, Radix Astragali 30-50 part.

The health product of above-mentioned a kind of blood fat reducing, preferred, process by following raw material medicaments in part by weight proportioning:

150 parts of nattokinase, 50 parts of hirudins, 30 parts of Pheretimas, 50 parts of Fructus Lyciis,

20 parts of Fructus Crataegis, 50 parts of Radix Salviae Miltiorrhizaes, 40 parts of the Radixs Astragali.

The health product of above-mentioned blood fat reducing are with processing tablet, capsule or pill behind the raw material medicaments in part by weight proportioning mix homogeneously.

Among the present invention,

Nattokinase:Being a kind of bacillus subtilis protein kinases, is a kind of serine protease that in the natto sweat, is produced by natto bacillus subtilis (Bacillus subtilisl natto).Effect with thrombus, anticoagulation, anti-platelet aggregation, microcirculation improvement.

Hirudin:Be extracted in Hirudo and the salivary gland thereof in the various active composition active significantly and a kind of composition of studying at most, the small protein that it is made up of 65-66 aminoacid (polypeptide).Hirudin has extremely strong inhibitory action to thrombin, be up to now the natural special inhibitor of the strongest thrombin of finding.Animal experiment and clinical research show that hirudin efficiently anticoagulation, antithrombotic forms, and further blood stasis phenomenons such as the thrombin activation of prevention catalyzed by thrombin and platelet response.

Pheretima:Contain compositions such as ground LONGSU, lumbrofebrin, vitamin B complex complex, have diuresis, ease pain, relieving asthma, effects such as blood pressure lowering, analgesic, convulsion.

Fructus Lycii:It is the multi-branched shrub plant of Solanaceae Lycium.Modern study, Fructus Lycii have blood sugar lowering, lipotropy, and can atherosclerosis.Nature and flavor are sweet; Property is put down; Return Liver Channel; Kidney channel; Lung meridian.Nourishing the liver; Nourishing kidney; Lung moistening.

Fructus Crataegi:Contain multivitamin, tartaric acid, citric acid, Crataegolic acid, malic acid etc., also contain mineral such as flavonoid, lactone, saccharide, protein, fat and calcium, phosphorus, ferrum.Fructus Crataegi can prevent and treat cardiovascular disease, has blood vessel dilating, heart tonifying, coronary blood flow increasing, improves the heart vigor, the stimulating central nervous system system, brings high blood pressure down and cholesterol, vessel softening and diuresis and sedation; Prevent and treat arteriosclerosis, anti-aging, anticancer effect.Crataegolic acid also has cardiotonic, and is also helpful to senile heart disease.

Radix Salviae Miltiorrhizae:Nature and flavor are bitter, are slightly cold.GUIXIN, Liver Channel.Has promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, the relieving restlessness that clears away heart-fire, the effect of nourishing blood to tranquillize the mind.Be used for menoxenia, the amenorrhea dysmenorrhea,, breast ventral spine pain, pyretic arthralgia pain, skin infection swells and ache, dysphoria and insomnia; Hepatosplenomegaly, angina pectoris.

The Radix Astragali:Property is sweet, tepor.Return lung, spleen, liver, kidney channel.Has the effect that benefiting QI for strengthening the superficies, arresting sweating take off, hold in the palm skin ulcer granulation promoting, inducing diuresis to remove edema admittedly.It is weak to be used to treat the deficiency of vital energy, sinking of QI of middle-JIAO, and the chronic diarrhea proctoptosis, the metrorrhagia of having blood in stool, the exterior deficiency spontaneous perspiration is burst for a long time and is not held back, blood deficiency and yellow complexion, interior-heat is quenched one's thirst, chronic nephritis, albuminuria, diabetes etc.

Clinical observation of the present invention is following:

1, physical data

Hyperlipemic patients 180 examples.

2, diagnostic criteria

It is normal that T-CHOL (TC) is lower than 5.20mmol/L (200mg/dl), and it is unusual to be higher than 5.72mmol/L (200mg/dl);

It is normal that low-density lipoprotein cholesterol (LDL--C) is lower than 3.12mmol/L (120mg/dl), and (140mg/dl is unusual to be higher than 3.64mmol/L;

It is normal that HDL-C (HDL--C) is higher than 1.04mmol/L (40mg/dl), and it is unusual to be lower than 0.91mmol/L (35mg/dl);

It is normal that triglyceride (TG) is lower than 1.70mmol/L (150mg/dl), and it is unusual to be higher than 1.70mmol/L (150mg/dl).

3, Therapeutic Method:

Every day early, middle and late three oral 1-3 capsules, capsule 0.3 gram/grain.

4, efficacy assessment standard

Produce effects: T-CHOL, low-density lipoprotein cholesterol, HDL-C and triglyceride (TG) value is normal;

Take a turn for the better: T-CHOL, low-density lipoprotein cholesterol, HDL-C and triglyceride (TG) value is normal basically, individual values is between normal value and the exceptional value;

Invalid: T-CHOL, low-density lipoprotein cholesterol, HDL-C and triglyceride (TG) are worth still in the exceptional value scope.

5, therapeutic outcome

Observation of curative effect after treatment

Edible through 3 months, produce effects 90 examples as a result, 80 examples that take a turn for the better, invalid 10 examples, total effective rate is 94.4%.

The invention has the beneficial effects as follows: the present invention adopts the technology of integration of edible and medicinal herbs, through the synergism of Chinese medicine and food, and can blood fat reducing; Blood viscosity reached in normal range; Because adopt the combination of Chinese medicine and food, toxic and side effects is little, and the curative effect of blood fat reducing is high.

The specific embodiment

The health product of 1 one kinds of blood fat reducing of embodiment

Process by following raw material medicaments in part by weight proportioning:

The above-mentioned raw materials medicine by behind the proportioning mix homogeneously, is prepared into capsule by routine techniques, capsule 0.3 gram/grain.

The health product of 2 one kinds of blood fat reducing of embodiment

Process by following raw material medicaments in part by weight proportioning:

150 parts of nattokinase, 40 parts of hirudins, 40 parts of Pheretimas, 40 parts of Fructus Lyciis,

10 parts of Fructus Crataegis, 60 parts of Radix Salviae Miltiorrhizaes, 30 parts of the Radixs Astragali.

The health product of 3 one kinds of blood fat reducing of embodiment

Process by following raw material medicaments in part by weight proportioning:

150 parts of nattokinase, 60 parts of hirudins, 20 parts of Pheretimas, 60 parts of Fructus Lyciis,

30 parts of Fructus Crataegis, 40 parts of Radix Salviae Miltiorrhizaes, 50 parts of the Radixs Astragali.

Claims

1. the health product of a blood fat reducing is characterized in that being processed by following raw material medicaments in part by weight proportioning:

2. according to the health product of the described a kind of blood fat reducing of claim 1, it is characterized in that processing by following raw material medicaments in part by weight proportioning:

3. according to the health product of claim 1 or 2 described a kind of blood fat reducing, it is characterized in that processing tablet, capsule or pill.